The PTAB recently instituted a second IPR of US Patent 9,296,821 (“the ’821 patent”), which covers certain uses of Rituxan®...
Jennifer P. Nock
- Posts: 3
-
-
Sanofi-Aventis U.S. LLC, Genzyme Corporation, and Regeneron Pharmaceuticals, Inc. recently scored a victory in their ongoing dispute over a...
-
As we previously reported here, earlier this year the Supreme Court agreed to hear its first case arising under the Biosimilars Price...